Use of low doses of manganese superoxide dismutase (mn-sod) in the treatment of diseases
Номер патента: CA2105612A1
Опубликовано: 10-03-1994
Автор(ы): Andreas Zophel, Christian Lillie, David R. Blake, Ewa J. Dowling
Принадлежит: Andreas Zophel, Bio-Technology General Corp., BOEHRINGER INGELHEIM INTERNATIONAL GMBH, Christian Lillie, David R. Blake, Ewa J. Dowling
Опубликовано: 10-03-1994
Автор(ы): Andreas Zophel, Christian Lillie, David R. Blake, Ewa J. Dowling
Принадлежит: Andreas Zophel, Bio-Technology General Corp., BOEHRINGER INGELHEIM INTERNATIONAL GMBH, Christian Lillie, David R. Blake, Ewa J. Dowling
Реферат: Abstract The present invention relates to the use of pharmaceutical preparations containing manganese superoxide dismutase in a low dose for treating diseases and conditions caused by free oxygen radicals.
Use of superoxide dismutase for the preparation of drugs for the prophylaxis and/or treatment of organ failure in risk patients having a polytrauma due to an accident
Номер патента: HK1005168A1. Автор: Volker Bühren,Leopold Flohe,Achim Schuttler,Ingo Marzi,Otmar Trentz. Владелец: Gruenenthal Chemie. Дата публикации: 1998-12-24.